Journal Articles

  1. & Psychometric development of the Upper Limb Lymphedema Quality of Life Questionnaire demonstrated the patient-reported outcome measure to be a robust measure for breast cancer–related lymphedema. Journal of Clinical Epidemiology 100, 61-70.
  2. & How to decide which patient-reported outcome measure to use? A practical guide for plastic surgeons. Journal of Plastic, Reconstructive & Aesthetic Surgery 71(7), 957-966.
  3. & How Are University Gyms Used by Staff and Students? A Mixed-Method Study Exploring Gym Use, Motivation, and Communication in Three UK Gyms. Societies 8(1), 15
  4. et. al. Predictive risk stratification model: a randomised stepped-wedge trial in primary care (PRISMATIC). Health Services and Delivery Research 6(1), 1-164.
  5. & Supervised exercise rehabilitation in survivors of critical illness: A randomised controlled trial. Journal of the Intensive Care Society, 175114371876706
  6. & Social Connectedness and Perceived Listening Effort in Adult Cochlear Implant Users. Ear and Hearing, 1
  7. & Long-term health effects after resolution of acute Cryptosporidium parvum infection: a 1-year follow-up of outbreak-associated cases. Journal of Medical Microbiology 66(11), 1607-1611.
  8. & The Readability of Online Patient Resources for Skin Cancer Treatment. Oncology and Therapy 5(2), 149-160.
  9. & Protocol for a multicentre randomised feasibility STUdy evaluating the impact of a prognostic model for Management of BLunt chest wall trauma patients: STUMBL trial. BMJ Open 7(7), e015972
  10. & Patient-Reported Outcome Measures in Routine Clinical Care: The PROMise of a Better Future?. Digestive Diseases and Sciences 62(8), 1841-1843.
  11. & Patient-reported outcome measures (PROMs) for assessing perceived listening effort in hearing loss: protocol for a systematic review. BMJ Open 7(5), e014995
  12. & Women’s Perceptions of Journeying Toward an Unknown Future With Breast Cancer: The “Lives at Risk Study”. Qualitative Health Research, 104973231773056
  13. & UK-based prospective cohort study to anglicise and validate the FACE-Q Skin Cancer Module in patients with facial skin cancer undergoing surgical reconstruction: the PROMISCR (Patient-Reported Outcome Measure in Skin Cancer Reconstruction) study. BMJ Open 7(9), e016182
  14. & Protocol for a multicentre randomised feasibility trial evaluating early Surgery Alone In LOw Rectal cancer (SAILOR). BMJ Open 6(11), e012496
  15. et. al. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. The Lancet Gastroenterology & Hepatology 1(1), 15-24.
  16. & Residential Moving and Preventable Hospitalizations. PEDIATRICS 138(1), e20152836-e20152836.
  17. & Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: pragmatic randomised Trial and economic evaluation (CONSTRUCT). Health Technology Assessment 20(44), 1-320.
  18. & Does frequent residential mobility in early years affect the uptake and timeliness of routine immunisations? An anonymised cohort study. Vaccine 34(15), 1773-1777.
  19. & Costs, effects and implementation of routine data emergency admission risk prediction models in primary care for patients with, or at risk of, chronic conditions: a systematic review protocol. BMJ Open 6(3), e009653
  20. & It could be a ‘Golden Goose’: a qualitative study of views in primary care on an emergency admission risk prediction tool prior to implementation. BMC Family Practice 17(1)
  21. & Validation of the Crohns and Ulcerative Colitis questionnaire in patients with acute severe ulcerative colitis. United European Gastroenterology Journal
  22. & Successful development and testing of a Method for Aggregating The Reporting of Interventions in Complex Studies (MATRICS). Journal of Clinical Epidemiology 69, 193-198.
  23. & Qualitative research and its methods in epilepsy: Contributing to an understanding of patients' lived experiences of the disease. Epilepsy & Behavior 45, 94-100.
  24. & Development and validation of the Gastrointestinal Endoscopy Satisfaction Questionnaire (GESQ). Endoscopy
  25. & Recent trends in the incidence of anxiety and prescription of anxiolytics and hypnotics in children and young people: An e-cohort study. Journal of Affective Disorders 183, 134-141.
  26. & The use of secure anonymised data linkage to determine changes in healthcare utilisation following severe open tibial fractures. Injury
  27. & Can the inflammatory bowel disease biologics registry lead to improved quality of care?. Journal of Taibah University Medical Sciences
  28. & Psychometric development of the Gastrointestinal Symptom Rating Questionnaire (GSRQ) demonstrated good validity. Journal of Clinical Epidemiology
  29. & Systematic Review of the Clinical Disease Severity Indices for Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 1
  30. & Systematic review of the health related quality of life (HRQoL) measures for inflammatory bowel disease. Journal of Crohn's and Colitis
  31. & Social deprivation and adult blunt chest trauma: A retrospective study. Journal of the Intensive Care Society 16(1), 18-23.
  32. & Wider consultation on Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease. Forum: Qualitative Social Research 16(1)
  33. & Development of a Short Questionnaire to Assess the Quality of Life in Crohn’s Disease and Ulcerative Colitis. Journal of Crohn's and Colitis 9(1), 66-76.
  34. & Predicting outcomes after blunt chest wall trauma: development and external validation of a new prognostic model. Critical Care 18(3), R98
  35. & The Effect of Pre-Injury Anti-Platelet Therapy on the Development of Complications in Isolated Blunt Chest Wall Trauma: A Retrospective Study. PLOS ONE
  36. & Nominal Group Technique consultation of a Pulmonary Rehabilitation Programme. F1000Research
  37. & Assessing patient reported outcome measures: A practical guide for gastroenterologists. United European Gastroenterology Journal
  38. & Randomised Controlled Trial to Compare Infliximab and Ciclosporin in Steroid Resistant Ulcerative Colitis: trial design and protocol. BMJ Open 4:e005091
  39. & Twice versus three-times weekly pulmonary rehabilitation in a real-life clinical setting. F1000Research
  40. & Has the Two Week Rule Improved Cancer Detection Rates for Gastrointestinal Cancers? A Systematic Literature Review. Current Cancer Therapy Reviews 2014(10)
  41. et. al. Involving service users in trials: developing a standard operating procedure. Trials 14(1), 219
  42. et. al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older in-patients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial.. Lancet
  43. et. al. A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE). Health Technology Assessment 17(57)
  44. Do Children Who Move Home and School Frequently Have Poorer Educational Outcomes in Their Early Years at School? An Anonymised Cohort Study. PLOS One 8, e70601
  45. & Chronic pain in survivors of critical illness: a retrospective analysis of incidence and risk factors. Critical Care 17(3), R101
  46. & Blunt chest wall trauma: A review. Trauma 15(2)-175.
  47. & Protocol for a prospective multicentre cohort study to develop and validate two new outcome measures for patients with inflammatory bowel disease. BMJ Open 3(7), e003192
  48. & Expert opinion of the risk factors for morbidity and mortality in blunt chest wall trauma: Results of a national postal questionnaire survey of Emergency Departments in the United Kingdom. Injury 44(1), 56-59.
  49. Obtaining consensus from mixed groups: An adapted Nominal Group work technique. British Journal of Medicine and Medical Research 3(3)-502.
  50. & Obtaining consensus about patient-centred professionalism in community nursing: nominal group work activity with professionals and the public. Journal of Advanced Nursing 68(11), 2429-2442.
  51. & The risk factors for the development of complications during the recovery phase following blunt chest. Injury
  52. & Risk factors that predict mortality in patients with blunt chest wall trauma: A systematic review and meta-analysis. Injury 43(1), 8-17.
  53. & Patient-centered professionalism. Patient Intelligence, 11
  54. & Barriers and facilitators to change in the organisation and delivery of endoscopy services in England and Wales: a focus group study. BMJ Open 2(3), e001009-e001009.
  55. & Bureaucracy stifles medical research in Britain: a tale of three trials. BMC Medical Research Methodology 12(1), 122
  56. & Patient-centred Professionalism and its impact on community pharmacists. The Pharmaceutical Journal 286
  57. & MATRICS: A Method for Aggregating The Reporting of Interventions in Complex Studies. Trials 12(Suppl 1), A147
  58. & A Randomised, Cross-Over, Placebo-Controlled Study of Aloe vera in Patients with Irritable Bowel Syndrome: Effects on Patient Quality of Life. ISRN Gastroenterology 2011, 1-8.
  59. & Eleven themes of patient-centred professionalism in community pharmacy: innovative approaches to consulting. International Journal of Pharmacy Practice 18(5), 260-268.
  60. & Burns in young children: a retrospective matched cohort study of health and developmental outcomes. Child: Care, health and development 36(6), DOI: 10.1111/j.1365-2214.2010.01106.x.
  61. & Obtaining consensus regarding patient-centred professionalism in community pharmacy: nominal group work activity with professionals, stakeholders and members of the public.. International Journal of Pharmacy Practice 18, 149-158.
  62. & An independent evaluation of the modernisation of NHS endoscopy services in England: data poverty and no improvement.. Journal of Evaluation of Clinical Practice 16, doi: 10.1111/j.1365-2753.2009.01177.x.
  63. & The impact of shift patterns on junior doctors' perceptions of fatigue, training, work/life balance and the role of social support. BMJ Quality & Safety 19(6), e36-e36.
  64. & The impact of junior doctors’ worktime arrangements on their fatigue and well-being. Scandinavian Journal of Work, Environment & Health 36(6), 458-465.
  65. & The Health Informatics Trial Enhancement Project (HITE): Using routinely collected primary care data to identify potential participants for a depression trial. Trials 11, 39
  66. & Evaluating Innovations in the Delivery and Organization of Endoscopy Services in England and Wales. Qualitative Health Research 20(7), 922-930.
  67. & Through the looking glass: public and professional perspectives on patient-centred professionalism in modern-day community pharmacy. Forum:Qualitative Social Research 11(1)
  68. & Do Not Attempt Resuscitation’- do standardised Order Forms make a clinical difference above hand-written note entries?. , 113-119.
  69. & Social health outcomes following thermal injuries: a retrospective matched cohort study. Archives of Disease in Childhood 94(9), 663-667.
  70. & The Two-Week Rule for NHS Gastrointestinal Cancer Referrals: A Systematic Review of Diagnostic Effectiveness. The Open Colorectal Cancer Journal 2(1), 27-33.
  71. & Development of a parent version of the Manchester-Minneapolis quality of life survey for use by parents and carers of UK children: MMQL-UK (PF). Health and Quality of Life Outcomes 6(1), 19
  72. & Unmeasured improvement work: the lack of routinely collected, service-related data in NHS endoscopy units in England involved in "modernisation". BMC Health Services Research 8(1)
  73. & Adaptation of the Manchester-Minneapolis Quality of Life instrument for use in the UK population. Archives of Disease in Childhood 92(10), 855-860.
  74. & Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut 56(suppl_1), 1-113.
  75. & The effects of the Two-Week Rule on NHS colorectal cancer diagnostic services: A systematic literature review. BMC Health Services Research 6(1)
  76. & The OPTION scale: measuring the extent that clinicians involve patients in decision-making tasks. Health Expectations 8(1), 34-42.
  77. & Can electronic routine data act as a surrogate for patient-assessed outcome measures?. International Journal of Technology Assessment in Health Care 21(1), 138-143.
  78. & Measurement properties of the UK-English version of the Pediatric Quality of Life InventoryTM 4.0 (PedsQLTM) generic core scales. Health and Quality of Life Outcomes 3(22)
  79. & Using a ‘peer assessment questionnaire’ in primary medical care.. British Journal of General Practice 55(518), 690-695.
  80. Assessing organisational development in primary medical care using a group based assessment: the Maturity MatrixTM. Quality and Safety in Health Care 13(4), 287-294.
  81. & Are obstetric risk factors and bowel symptoms associated with defaecographic and manometric abnormalities in women awaiting hysterectomy?. J Obstet Gynaecol 24(3), 274-8.
  82. & The value of routine data in health technology assessment: Can randomised trials rely on existing electronic data? A feasibility study to explore the value of routine data in health technology assessment.. Health Technology Assessment 7(26)
  83. & Estimating the marginal value of ?better? research output: ?designed? versus ?routine? data in randomised controlled trials. Health Economics 12(11), 959-974.
  84. & Autologous blood transfusion in total knee replacement surgery. British Journal of Anaesthesia 86(5), 669-673.
  85. & Case-control study of the health of those looked after by local authorities. Archives of Disease in Childhood 85(4), 280-285.
  86. & Population requirement for adult critical care beds: a prospective quantitative and qualitative study. Lancet 355, 595-598.
  87. Sarcoidosis: a long term follow-up study.. Journal of Sarcoidosis Vasculitis and Diffuse Lung Diseases 17, 167-73.
  88. & SF-36 scores vary by method of administration: implications for study design.. Journal of Public Health Medicine 21(1), 41-45.
  89. & The opioid agonist codeine and antagonist naltrexone do not affect voluntary suppression of capsaicin induced cough in healthy subjects. European Respiratory Journal 7, 715-719.
  90. & Voluntary suppression of cough induced by inhalation of capsaicin in healthy volunteers. Respiratory Medicine 87(5), 379-382.
  91. & Voluntary cough suppression as an indication of symptom severity in upper respiratory tract infections. European Respiratory Journal 6, 1449-1454.
  92. & The relationship between nasalance and nasal resistance to airflow. Acta Otolaryngol (Stokh) 110, 443-449.